Industry News

Industry News

Instructional Web-Based Video Decreases Patient No-Shows For Colonoscopy

May 21, 2012

Patients who watch an online instructional video are more likely to keep their appointments and arrive prepared for a scheduled colonoscopy than those who do not, according to a study by gastroenterologists at the University of Chicago Medicine... Read More

Improving Cancer Patients' Quality Of Life By A Nurse Practitioner-Driven Palliative Care Intervention

May 21, 2012

Recent studies have shown that palliative care interventions aimed at addressing patients' emotional, spiritual and social needs have a significant impact on cancer patients' quality of life and may even improve cancer patients' overall survival. Despite this, most cancer patients being cared for in their communities do not have access to these services... Read More

In Heart Transplant Recipients, Statins May Prevent Cancer

May 21, 2012

Statins prevent cancer and reduce death from all causes in heart transplant recipients. The findings were independent of cholesterol levels. The research was presented at the Heart Failure Congress 2012, 19-22 May, in Belgrade, Serbia. The Congress is the main annual meeting of the Heart Failure Association of the European Society of Cardiology... Read More

Researchers Identify New Key Mechanism In Cell Division

May 21, 2012

Researchers from the Bellvitge Biomedical Research Institute (IDIBELL) have identified the mechanism by which protein Zds1 regulates a key function in mitosis, the process that occurs immediately before cell division. The result has been achieved in the online edition of the Journal of Cell Science and opens the door to developing targeted and direct therapies against cancer... Read More

Hybrid Vaccine Demonstrates Potential To Prevent Breast Cancer Recurrence

May 21, 2012

A breast cancer vaccine already shown to elicit a powerful immune response in women with varying levels of HER2 expression has the ability to improve recurrence rates and is well tolerated in an adjuvant setting, according to new research from a clinical trial led by researchers at The University of Texas MD Anderson Cancer Center... Read More

Generic Versions Of Blood Thinning Plavix Approved By FDA

May 20, 2012

Generic versions of blood-thinning medication - Plavix (clopidogrel bisulfate) - have been approved by the FDA (Food and Drug Administration). Clopidogrel bisulfate reduces the likelihood of blood platelets clumping together and forming clots in blood vessels, resulting in a lower risk of stroke and heart attack... Read More

Generic Versions Of Blood Thinning Plavix Approved By FDA

May 20, 2012

Generic versions of blood-thinning medication - Plavix (clopidogrel bisulfate) - have been approved by the FDA (Food and Drug Administration). Clopidogrel bisulfate reduces the likelihood of blood platelets clumping together and forming clots in blood vessels, resulting in a lower risk of stroke and heart attack... Read More

Discovery Alters Prevailing View Of Splicing Regulation And Has Implications For Splicing Mutations Associated With Disease

May 20, 2012

There are always exceptions to a rule, even one that has prevailed for more than three decades, as demonstrated by a Cold Spring Harbor Laboratory (CSHL) study on RNA splicing, a cellular editing process... Read More

Discovery Alters Prevailing View Of Splicing Regulation And Has Implications For Splicing Mutations Associated With Disease

May 20, 2012

There are always exceptions to a rule, even one that has prevailed for more than three decades, as demonstrated by a Cold Spring Harbor Laboratory (CSHL) study on RNA splicing, a cellular editing process... Read More

Hormone-Depleting Drug Shows Promise Against Localized High-Risk Prostate Tumors

May 19, 2012

A hormone-depleting drug approved last year for the treatment of metastatic prostate cancer can help eliminate or nearly eliminate tumors in many patients with aggressive cancers that have yet to spread beyond the prostate, according to a clinical study to be presented at the annual meeting of the American Society of Clinical Oncology (ASCO), June 1-5, in Chicago... Read More

Previous Page   Next Page